Tetanus Toxin C-Fragment: The Courier and the Cure?
AbstractIn many neurological disorders strategies for a specific delivery of a biological activity from the periphery to the central nervous system (CNS) remains a considerable challenge for successful therapy. Reporter assays have established that the non-toxic C‑fragment of tetanus toxin (TTC), provided either as protein or encoded by non-viral naked DNA plasmid, binds pre-synaptic motor neuron terminals and can facilitate the retrograde axonal transport of desired therapeutic molecules to the CNS. Alleviated symptoms in animal models of neurological diseases upon delivery of therapeutic molecules offer a hopeful prospect for TTC therapy. This review focuses on what has been learned on TTC-mediated neuronal targeting, and discusses the recent discovery that, instead of being merely a carrier molecule, TTC itself may well harbor neuroprotective properties.
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Toivonen, J.M.; Oliván, S.; Osta, R. Tetanus Toxin C-Fragment: The Courier and the Cure? Toxins 2010, 2, 2622-2644.
Toivonen JM, Oliván S, Osta R. Tetanus Toxin C-Fragment: The Courier and the Cure? Toxins. 2010; 2(11):2622-2644.Chicago/Turabian Style
Toivonen, Janne M.; Oliván, Sara; Osta, Rosario. 2010. "Tetanus Toxin C-Fragment: The Courier and the Cure?" Toxins 2, no. 11: 2622-2644.